[{"Assets_0_Q3_USD":604905000.0,"CommonStockSharesOutstanding_0_Q3_shares":162511940.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":-103785000.0,"NetIncomeLoss_1_Q3_USD":-53634000.0,"NetIncomeLoss_3_Q3_USD":-153109000.0,"StockholdersEquity_0_Q3_USD":228421000.0,"Ticker":"PGEN","CIK":"1356090","name":"INTREXON CORP","OfficialName":"Precigen Inc. Common Stock","form":"10-Q","period":"20190930","fy":"2019.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"337298902.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Commercial Physical & Biological Resarch","Market":"NASDAQ","SP500":"nan","filed":"20191112"}]